• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PYCR1 通过影响 Akt/Wnt/β-连环蛋白信号通路促进膀胱癌。

PYCR1 promotes bladder cancer by affecting the Akt/Wnt/β-catenin signaling.

机构信息

Department of Urology, Shaanxi Provincial People's Hospital, Xi'an, 710068, China.

Department of Physical Examination, Shaanxi Provincial People's Hospital, No.256 Youyi West Road, Xi'an, 710068, China.

出版信息

J Bioenerg Biomembr. 2021 Apr;53(2):247-258. doi: 10.1007/s10863-021-09887-3. Epub 2021 Mar 10.

DOI:10.1007/s10863-021-09887-3
PMID:33689096
Abstract

Pyrroline-5-carboxylate reductase 1 (PYCR1) plays a significant role in the malignant progression of various cancers. However, the role of PYCR1 in bladder cancer has not been well studied. This study was performed to evaluate the potential relevance of PYCR1 in bladder cancer. Our data revealed that PYCR1 expression was increased in bladder cancer tissues, and increased expression of PYCR1 was predictive of decreased survival rates. In bladder cancer cell lines, knockdown of PYCR1 caused significantly retarded cell growth and invasion, while PYCR1 overexpression accelerated cellular proliferation and invasion. Moreover, PYCR1 knockdown decreased levels of phosphorylated Akt, and enhanced activation of Wnt/β-catenin signaling. Akt inhibition markedly abrogated of PYCR1 overexpression-mediated activation of Wnt/β-catenin signaling. In addition, overexpression of β-catenin partially reversed PYCR1 knockdown-mediated tumor suppression. Notably, PYCR1 knockdown significantly impeded tumor formation and growth in bladder cancer cells in vivo. In conclusion, these data demonstrate that PYCR1 is highly expressed in bladder cancer and knockdown of PYCR1 exerts a remarkable inhibitory effect on tumor formation via downregulation of Akt/Wnt/β-catenin signaling. Our study suggests a potential role for PYCR1 in promoting bladder cancer progression and indicates that PYCR1 may be utilized as an attractive and promising anticancer target for treatment of bladder cancer.

摘要

吡咯啉-5-羧酸还原酶 1(PYCR1)在多种癌症的恶性进展中发挥重要作用。然而,PYCR1 在膀胱癌中的作用尚未得到充分研究。本研究旨在评估 PYCR1 在膀胱癌中的潜在相关性。我们的数据显示,PYCR1 在膀胱癌组织中表达增加,PYCR1 表达增加预示着生存率降低。在膀胱癌细胞系中,敲低 PYCR1 导致细胞生长和侵袭明显延迟,而过表达 PYCR1 则加速细胞增殖和侵袭。此外,PYCR1 敲低降低了磷酸化 Akt 的水平,并增强了 Wnt/β-catenin 信号通路的激活。Akt 抑制显著阻断了 PYCR1 过表达介导的 Wnt/β-catenin 信号通路的激活。此外,β-catenin 的过表达部分逆转了 PYCR1 敲低介导的肿瘤抑制。值得注意的是,PYCR1 敲低显著抑制了膀胱癌细胞在体内的肿瘤形成和生长。总之,这些数据表明,PYCR1 在膀胱癌中高表达,敲低 PYCR1 通过下调 Akt/Wnt/β-catenin 信号通路对肿瘤形成产生显著抑制作用。本研究提示 PYCR1 在促进膀胱癌进展中可能具有潜在作用,并表明 PYCR1 可作为治疗膀胱癌有吸引力和有前途的抗癌靶点。

相似文献

1
PYCR1 promotes bladder cancer by affecting the Akt/Wnt/β-catenin signaling.PYCR1 通过影响 Akt/Wnt/β-连环蛋白信号通路促进膀胱癌。
J Bioenerg Biomembr. 2021 Apr;53(2):247-258. doi: 10.1007/s10863-021-09887-3. Epub 2021 Mar 10.
2
BHLHE41 inhibits bladder cancer progression via regulation of PYCR1 stability and thus inactivating PI3K/AKT signaling pathway.BHLHE41 通过调节 PYCR1 的稳定性来抑制膀胱癌的进展,从而使 PI3K/AKT 信号通路失活。
Eur J Med Res. 2024 May 29;29(1):302. doi: 10.1186/s40001-024-01889-2.
3
KLK11 acts as a tumor-inhibitor in laryngeal squamous cell carcinoma through the inactivation of Akt/Wnt/β-catenin signaling.KLK11通过使Akt/Wnt/β-连环蛋白信号失活,在喉鳞状细胞癌中发挥肿瘤抑制作用。
J Bioenerg Biomembr. 2021 Feb;53(1):85-96. doi: 10.1007/s10863-020-09870-4. Epub 2021 Jan 9.
4
SKA3 promotes glioblastoma proliferation and invasion by enhancing the activation of Wnt/β-catenin signaling via modulation of the Akt/GSK-3β axis.SKA3 通过调节 Akt/GSK-3β 轴增强 Wnt/β-catenin 信号通路的激活,促进胶质母细胞瘤的增殖和侵袭。
Brain Res. 2021 Aug 15;1765:147500. doi: 10.1016/j.brainres.2021.147500. Epub 2021 Apr 22.
5
Knockdown of TRIM26 inhibits the proliferation, migration and invasion of bladder cancer cells through the Akt/GSK3β/β-catenin pathway.TRIM26 通过 Akt/GSK3β/β-catenin 通路抑制膀胱癌细胞的增殖、迁移和侵袭。
Chem Biol Interact. 2021 Mar 1;337:109366. doi: 10.1016/j.cbi.2021.109366. Epub 2021 Feb 4.
6
LHPP exerts a tumor-inhibiting role in glioblastoma via the downregulation of Akt and Wnt/β-catenin signaling.LHPP通过下调Akt和Wnt/β-连环蛋白信号传导,在胶质母细胞瘤中发挥肿瘤抑制作用。
J Bioenerg Biomembr. 2021 Feb;53(1):61-71. doi: 10.1007/s10863-020-09866-0. Epub 2021 Jan 4.
7
Cathepsin C Promotes Tumorigenesis in Bladder Cancer by Activating the Wnt/β-catenin Signalling Pathway.组织蛋白酶 C 通过激活 Wnt/β-连环蛋白信号通路促进膀胱癌发生。
Front Biosci (Landmark Ed). 2024 Sep 23;29(9):327. doi: 10.31083/j.fbl2909327.
8
LSINCT5 activates Wnt/β-catenin signaling by interacting with NCYM to promote bladder cancer progression.LSINCT5 通过与 NCYM 相互作用激活 Wnt/β-catenin 信号通路,促进膀胱癌的进展。
Biochem Biophys Res Commun. 2018 Jul 20;502(3):299-306. doi: 10.1016/j.bbrc.2018.05.076. Epub 2018 May 30.
9
EFEMP2 suppresses epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in human bladder cancer.EFEMP2 通过 Wnt/β-catenin 信号通路抑制人膀胱癌中的上皮-间质转化。
Int J Biol Sci. 2019 Aug 8;15(10):2139-2155. doi: 10.7150/ijbs.35541. eCollection 2019.
10
TMEM88 exhibits an antiproliferative and anti-invasive effect in bladder cancer by downregulating Wnt/β-catenin signaling.TMEM88 通过下调 Wnt/β-catenin 信号通路抑制膀胱癌的增殖和侵袭。
J Biochem Mol Toxicol. 2021 Aug;35(8):e22835. doi: 10.1002/jbt.22835. Epub 2021 May 31.

引用本文的文献

1
The key enzyme PYCR1 in proline metabolism: a dual driver of cancer progression and fibrotic remodeling.脯氨酸代谢中的关键酶PYCR1:癌症进展和纤维化重塑的双重驱动因素
J Enzyme Inhib Med Chem. 2025 Dec;40(1):2545620. doi: 10.1080/14756366.2025.2545620. Epub 2025 Sep 2.
2
Hypoxia-induced PYCR1 regulates glycolysis and histone lactylation to promote bladder cancer progression and metastasis via SLC6A14/Glutamine metabolism.缺氧诱导的PYCR1通过SLC6A14/谷氨酰胺代谢调节糖酵解和组蛋白乳酸化,以促进膀胱癌的进展和转移。
Cancer Biol Ther. 2025 Dec;26(1):2546219. doi: 10.1080/15384047.2025.2546219. Epub 2025 Aug 13.
3

本文引用的文献

1
Pyrroline-5-carboxylate reductase 1 promotes proliferation and inhibits apoptosis in non-small cell lung cancer.吡咯啉-5-羧酸还原酶1促进非小细胞肺癌的增殖并抑制其凋亡。
Oncol Lett. 2018 Jan;15(1):731-740. doi: 10.3892/ol.2017.7400. Epub 2017 Nov 14.
9-Deazaadenosine directly binds PYCR1 and inhibits cancer cell proliferation through disruption of NAD+ metabolism.
9-脱氮腺苷直接结合PYCR1,并通过破坏NAD+代谢来抑制癌细胞增殖。
Transl Oncol. 2025 Jul 23;60:102478. doi: 10.1016/j.tranon.2025.102478.
4
[A pan-cancer analysis of PYCR1 and its predictive value for chemotherapy and immunotherapy responses in bladder cancer].[PYCR1的泛癌分析及其对膀胱癌化疗和免疫治疗反应的预测价值]
Nan Fang Yi Ke Da Xue Xue Bao. 2025 Apr 20;45(4):880-892. doi: 10.12122/j.issn.1673-4254.2025.04.24.
5
ITPKA phosphorylates PYCR1 and promotes the progression of glioma.ITPKA使PYCR1磷酸化并促进胶质瘤进展。
Heliyon. 2024 Jul 30;10(15):e35303. doi: 10.1016/j.heliyon.2024.e35303. eCollection 2024 Aug 15.
6
Screening a knowledge-based library of low molecular weight compounds against the proline biosynthetic enzyme 1-pyrroline-5-carboxylate 1 (PYCR1).针对脯氨酸生物合成酶 1-吡咯啉-5-羧酸 1(PYCR1)筛选基于知识的小分子化合物文库。
Protein Sci. 2024 Jul;33(7):e5072. doi: 10.1002/pro.5072.
7
Deciphering the Effects of the PYCR Family on Cell Function, Prognostic Value, Immune Infiltration in ccRCC and Pan-Cancer.解析 PYCR 家族对 ccRCC 及泛癌中细胞功能、预后价值、免疫浸润的影响。
Int J Mol Sci. 2024 Jul 25;25(15):8096. doi: 10.3390/ijms25158096.
8
Integrative analysis of Anoikis-related genes reveals that FASN is a novel prognostic biomarker and promotes the malignancy of bladder cancer via Wnt/β-catenin pathway.失巢凋亡相关基因的综合分析表明,脂肪酸合酶是一种新的预后生物标志物,并通过Wnt/β-连环蛋白途径促进膀胱癌的恶性发展。
Heliyon. 2024 Jul 3;10(13):e34029. doi: 10.1016/j.heliyon.2024.e34029. eCollection 2024 Jul 15.
9
BHLHE41 inhibits bladder cancer progression via regulation of PYCR1 stability and thus inactivating PI3K/AKT signaling pathway.BHLHE41 通过调节 PYCR1 的稳定性来抑制膀胱癌的进展,从而使 PI3K/AKT 信号通路失活。
Eur J Med Res. 2024 May 29;29(1):302. doi: 10.1186/s40001-024-01889-2.
10
Novel Fragment Inhibitors of PYCR1 from Docking-Guided X-ray Crystallography.基于对接引导的 X 射线晶体学研究新型 PYCR1 片段抑制剂
J Chem Inf Model. 2024 Mar 11;64(5):1704-1718. doi: 10.1021/acs.jcim.3c01879. Epub 2024 Feb 27.